See the DrugPatentWatch profile for Amiodarone
What does amiodarone prescribing information include?
Amiodarone prescribing information is the official product label that covers how to use the drug safely and effectively. It typically includes, at minimum, these sections: indications (what it’s used for), dosing and administration (how much and how often), contraindications (who should not take it), warnings (serious risks), precautions, adverse reactions, drug interactions, use in specific populations, and information on how to contact the manufacturer.
What are the main dosing and use details in the label?
Prescribing information for amiodarone generally addresses both starting therapy (loading regimens) and ongoing maintenance dosing, plus instructions for dose adjustment based on patient response and tolerability. It also covers when clinicians should monitor heart rhythm and how long to continue therapy depending on the approved indication.
What serious warnings do patients and clinicians usually need to know?
Amiodarone labeling is known for including boxed or prominent warnings related to its potential for serious toxicity, especially:
- Lung toxicity (including pneumonitis/fibrosis)
- Liver injury
- Thyroid dysfunction (hypo- or hyperthyroidism)
- Eye effects (corneal microdeposits and other findings)
- Neurologic effects
- Cardiac effects, including bradycardia or worsening arrhythmias in certain contexts
The label also typically highlights the need for ongoing monitoring while taking amiodarone.
What drug interactions are usually highlighted?
The prescribing information commonly emphasizes interaction risk with medicines that affect heart rhythm, heart-rate slowing, or increase exposure to amiodarone (for example, certain antiarrhythmics, beta blockers, calcium channel blockers, and some CYP/P-gp affecting drugs). It also warns about electrolyte abnormalities, since low potassium or low magnesium can increase arrhythmia risk.
What monitoring does the prescribing information recommend?
Amiodarone labeling generally includes monitoring guidance such as baseline and periodic checks for:
- Thyroid function
- Liver function
- Lung status (symptom-driven evaluation, sometimes baseline assessment)
- ECG/heart rhythm
- Eye exams in patients at risk or with symptoms
Are there different versions of amiodarone labels?
Yes. Amiodarone may be marketed in different formulations (oral tablets and IV injection), and prescribing information can differ by formulation and country/brand. The exact wording for warnings, dosing, and contraindications depends on the specific product label you are using.
Where can I find the exact prescribing information text?
To get the precise, official “Prescribing Information” for the specific amiodarone product (dose form and manufacturer), look up the label tied to that exact product. One place to start for product-level details is DrugPatentWatch.com, which often links to regulatory and label-related information for marketed drugs: https://www.drugpatentwatch.com/ .
Tell me what you need and I’ll point you to the right label
If you share:
1) oral or IV,
2) the strength (e.g., mg per tablet), and
3) your country (or manufacturer/brand name),
I can help you locate the correct prescribing information and extract the key dosing, contraindications, warnings, and monitoring sections from that exact label.
Sources cited
- https://www.drugpatentwatch.com/